Supplements That May Help OCD Symptoms: The Evidence

Obsessive-compulsive disorder (OCD) affects approximately 2-3% of the global population and is characterized by intrusive, unwanted thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to reduce distress. Unlike many anxiety disorders, OCD involves a specific neurobiological profile: dysfunction in the cortico-striato-thalamo-cortical (CSTC) circuit, serotonin dysregulation, and critically, glutamate hyperactivity.

This glutamate component is important because it's why standard SSRIs don't work as well for OCD as they do for depression, and why certain supplements with glutamate-modulating properties have shown particular promise.

All supplements discussed here are adjunctive — to be used alongside, not instead of, evidence-based treatments (ERP therapy and/or SSRIs/clomipramine). Discuss with your psychiatrist before adding supplements.

N-Acetyl Cysteine (NAC): The Most Promising Option

NAC is a precursor to glutathione (antioxidant) but its relevance to OCD comes from a different mechanism: NAC is converted to cystine, which acts as a cystine-glutamate antiporter in the brain. This system regulates extracellular glutamate levels. By restoring cystine-glutamate exchange, NAC reduces excessive glutamate in the striatum — a key OCD-implicated area.

The clinical evidence is meaningful. A double-blind RCT published in the Journal of Clinical Psychiatry by Afshar et al. (2012) found that NAC (2,400mg/day in two doses) as an add-on to SSRIs significantly reduced Y-BOCS (Yale-Brown Obsessive Compulsive Scale) scores compared to placebo at 16 weeks, with no significant adverse effects. A meta-analysis and multiple additional trials support this benefit.

Dose: 600-1,200mg twice daily (1,200-2,400mg/day total). Start at 600mg/day and increase gradually. Take with food to reduce nausea. Do not combine with nitrate medications.

Inositol

Myo-inositol acts as a second messenger for serotonin (5-HT2 receptor pathway) and other receptors implicated in OCD. A double-blind crossover trial by Fux et al. compared 18g/day of inositol to fluvoxamine (a standard OCD SSRI) and found comparable efficacy in reducing OCD symptoms with inositol having fewer side effects.

Subsequent research has been mixed — some trials showed benefit, others did not. The heterogeneity of OCD subtypes may explain this variance. Inositol appears most promising for OCD with comorbid depression or panic.

Dose: Titrate slowly from 2g/day up to 12-18g/day over 3-4 weeks. Available as inexpensive powder. Main side effects are GI (loose stools at high doses). Safe to combine with NAC.

Milk Thistle (Silymarin)

This is a less obvious entry. Silymarin, the active extract of milk thistle, has demonstrated glutamate-modulating properties and potent antioxidant effects in the brain. An RCT published in Progress in Neuropsychopharmacology & Biological Psychiatry found that silymarin (600mg/day) as an SSRI augmentation strategy significantly reduced Y-BOCS scores compared to placebo in 6 weeks.

The effect size was comparable to NAC. Silymarin also has excellent hepatoprotective effects and is generally very well-tolerated. This makes it a useful option particularly for patients already on SSRIs who want adjunctive support with minimal interaction risk.

Dose: 140-600mg/day standardized silymarin extract (standardized to 70-80% silymarin content).

Sarcosine (N-methylglycine)

Sarcosine is a glycine transporter-1 (GlyT1) inhibitor that enhances NMDA receptor function. Since OCD involves overactive glutamate in parts of the CSTC circuit, the paradox of using an NMDA enhancer might seem counterintuitive — but the research suggests sarcosine reduces OCD symptoms, possibly through modulating glutamate signaling indirectly.

A small RCT in a Taiwanese population found sarcosine (2,000mg/day) significantly reduced OCD symptoms over 6 weeks. The evidence base is thin but mechanistically interesting. Sarcosine is also studied for schizophrenia and depression.

Omega-3 Fatty Acids

Omega-3 supplementation reduces neuroinflammation and modulates serotonin and dopamine signaling. The evidence for OCD specifically is limited, but omega-3s are broadly neuroprotective and complement SSRI treatment (they enhance SSRI response in depression via synergistic mechanisms).

A pilot study found EPA-rich omega-3 supplementation reduced OCD symptom severity modestly. Given the overall safety and broad benefits, 2-3g/day EPA+DHA is a reasonable baseline supplement for anyone with OCD.

FAQ

Can supplements replace SSRIs or ERP therapy for OCD? No. ERP (Exposure and Response Prevention) therapy is the most effective treatment for OCD and produces lasting structural brain changes. SSRIs or clomipramine reduce symptom severity. Supplements can reduce residual symptoms or augment medication response, but the evidence base is nowhere near sufficient to support using them as standalone treatments.

How long does NAC take to work for OCD? The Afshar RCT showed significant Y-BOCS reductions emerging between weeks 8-16. Expect a minimum of 8 weeks at therapeutic doses before evaluating response.

Are there any supplement-SSRI interactions to know about? St. John's Wort: avoid — causes significant CYP450 interactions and reduces SSRI blood levels. High-dose saffron or 5-HTP with SSRIs: theoretical serotonin syndrome risk. NAC, inositol, milk thistle, and omega-3s are generally safe to combine with SSRIs, but always disclose to your prescriber.

Related Articles

• Supplements for OCD: Adjunctive Options with Evidence
• Inositol for Anxiety and OCD: The Second Messenger Supplement
• NAC for Mental Health: Glutamate Modulation and Compulsive Behaviors
• Best Supplements for Anxiety: Natural, Evidence-Based Options That Work
• Best Supplements for Anxiety: Evidence-Based Natural Solutions That Work

Track your supplements in Optimize.